KOD on Nasdaq

Kodiak Sciences Inc.

Logo: kodiak.com4

Biotech company.1

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with another stock.

  • TickerKOD on Nasdaq1
  • IndustryBiological Products, (No Diagnostic Substances)1
  • HeadquartersPalo Alto1
  • Websitekodiak.com
  • Legal formDelaware corporation1
  • Incorporated inDE5
  • Business address1250 Page Mill Rd, Palo Alto, Ca 943045
  • Filer categoryNon-accelerated filer, Smaller reporting company5
  • LEI254900IXI5NI8C9OQE243
  • StatusActive3
  • LEI statusIssued and current3
  • Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States3
  • Registered withDivision of Corporations, Department of State, 47016343

See how the biggest companies compare on our leaderboards

Kodiak Sciences Inc. image from its website
Image: kodiak.com4

Since its founding in 2009, Kodiak Sciences Inc. (“Kodiak,” the “Company,” “we” or “our”) has developed a new technology platform, the Antibody Biopolymer Conjugate (“ABC”) platform, for retinal medicines. Our goal is to prevent and treat the major causes of blindness by developing and commercializing next-generation therapeutics to address multiple unmet needs on the spectrum of retinal diseases.6 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income7891011-$234.4M in 2025+376% since 2019
-$400.0M-$300.0M-$200.0M-$100.0M02019: -$49.2M-$49.2M20192020: -$136.0M-$136.0M2020+176%2021: -$267.1M-$267.1M2021+96%2022: -$341.4M-$341.4M2022+28%2023: -$277.3M-$277.3M2023−19%2024: -$186.8M-$186.8M2024−33%2025: -$234.4M-$234.4M2025+25%
Net income7891011-$230.0M in 2025+386% since 2019
-$400.0M-$300.0M-$200.0M-$100.0M02019: -$47.4M-$47.4M20192020: -$133.1M-$133.1M2020+181%2021: -$267.0M-$267.0M2021+101%2022: -$333.8M-$333.8M2022+25%2023: -$260.5M-$260.5M2023−22%2024: -$176.2M-$176.2M2024−32%2025: -$230.0M-$230.0M2025+31%

Every line of the income statement as filed: the last 3 fiscal years, latest first.11

Period ending2025-12-312024-12-312023-12-31
Research and development$182.4M$126.1M$206.3M
General and administrative$52.0M$60.8M$71.0M
Total operating expenses$234.4M$186.8M$277.3M
Loss from operations-$234.4M-$186.8M-$277.3M
Interest income$4.5M$11.1M$16.7M
Interest expense$0$0-$13.0K
Other income (expense), net-$96.0K-$506.0K$110.0K
Net loss-$230.0M-$176.2M-$260.5M
Net loss per share common share, basic-$4.32-$3.35-$4.97
Net loss per share common share, diluted-$4.32-$3.35-$4.97
Weighted-average shares of common stock outstanding used in computing net loss per common share, basic53.2M shares52.6M shares52.4M shares
Weighted-average shares of common stock outstanding used in computing net loss per common share, diluted53.2M shares52.6M shares52.4M shares
Change in unrealized gains (losses) related to available-for-sale debt securities, net of tax$0$0$1.3M
Total other comprehensive income (loss)$0$0$1.3M
Comprehensive loss-$230.0M-$176.2M-$259.2M

Compare Kodiak Sciences Inc. with another company

Leadership

Who has led Kodiak Sciences Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Victor Perlroth2018–now

Chair

  1. Victor Perlroth2018–now

President

  1. Michael Weiser2006
  2. Matthew H. Davis2008
  3. Victor Perlroth2018–2021

Chief financial officer

  1. John A. Borgeson2026–now
2010201520202025
Board members and other officers (13)

Former names

  • Oligasis, LLCJul 28, 2009 to Jul 28, 20095

Timeline

  1. Oct 3, 2018New chief executive Victor Perlroth becomes CEO15
  2. Jun 22, 2009Founded Kodiak Sciences Inc. is founded3

Filings

196 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 34 major events, 81 insider forms, 28 large holders, 33 other. The latest 20:

  1. Sep 30, 20264 EDGAR
  2. Sep 30, 20264 EDGAR
  3. Sep 30, 20264 EDGAR
  4. Sep 30, 2026SCHEDULE 13D/A EDGAR
  5. Sep 29, 20264 EDGAR
  6. Sep 28, 20268-K EDGAR
  7. Aug 14, 2026SCHEDULE 13G EDGAR
  8. Aug 13, 202610-Q EDGAR
  9. Aug 13, 20268-K EDGAR
  10. Jul 17, 20264 EDGAR
  11. Jul 17, 20264 EDGAR
  12. Jul 2, 20264 EDGAR
  13. Jul 2, 20264 EDGAR
  14. Jul 2, 20264 EDGAR
  15. Jul 2, 20264 EDGAR
  16. Jul 2, 20264 EDGAR
  17. Jul 2, 20264 EDGAR
  18. Jun 5, 20264 EDGAR
  19. Jun 4, 2026144 EDGAR
  20. Jun 4, 20268-K EDGAR

The 196 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

43 open-market trades by officers, directors and large owners since October 2021: 23 buys and 20 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 29, 2026667, L.P.DirectorBuy33,726$85.04$2.9MForm 4
Sep 28, 2026667, L.P.DirectorBuy681,866$88.77$60.5MForm 4
Sep 28, 2026BAKER JULIANDirectorBuy418,323$83.58$35.0MForm 4
Sep 28, 2026Baker Bros. Advisors (GP) LLCDirectorBuy807,840$72.57$58.6MForm 4
Jun 4, 2026BORGESON JOHN A.Chief Financial OfficerSale30,000$34.10$1.0MForm 4
Apr 2, 2026BORGESON JOHN A.Chief Financial OfficerSale30,000$39.92$1.2MForm 4
Dec 18, 2025Baker Brothers Life Sciences LPDirectorBuy2,608,696$23.00$60.0MForm 4
Jun 17, 2025BORGESON JOHN A.Chief Financial OfficerSale723$3.65$2.6KForm 4
Jun 17, 2024BORGESON JOHN A.Chief Financial OfficerSale2,874$2.75$7.9KForm 4
Jun 12, 2024BORGESON JOHN A.Chief Financial OfficerSale1,558$2.92$4.5KForm 4
Jun 16, 2023EHRLICH JASONSee RemarksSale2,258$9.23$20.8KForm 4
Jun 16, 2023BORGESON JOHN A.Chief Financial OfficerSale2,749$9.23$25.4KForm 4
Jun 14, 2023EHRLICH JASONSee RemarksSale1,132$9.42$10.7KForm 4
Jun 14, 2023BORGESON JOHN A.Chief Financial OfficerSale1,448$9.42$13.6KForm 4
Jun 17, 2022EHRLICH JASONSee RemarksSale2,282$7.02$16.0KForm 4
Jun 17, 2022BORGESON JOHN A.Chief Financial OfficerSale2,798$7.02$19.6KForm 4
Jun 15, 2022EHRLICH JASONSee RemarksSale1,205$7.21$8.7KForm 4
Jun 15, 2022BORGESON JOHN A.Chief Financial OfficerSale1,545$7.21$11.1KForm 4
Jun 6, 2022Baker Bros. Advisors (GP) LLCDirectorBuy303,917$7.77$2.4MForm 4
Jun 3, 2022Baker Bros. Advisors (GP) LLCDirectorBuy102,200$7.95$812.2KForm 4

All 43 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Baker Bros. Advisors LP19,919,186$776.1M3.9%No change
BlackRock, Inc.4,135,355$161.1M0.0%+200,053
State Street Corp2,419,417$94.3M0.0%+168,497
Goldman Sachs Group Inc2,316,014$90.2M0.0%+627,011
Vanguard Capital Management LLC1,804,632$70.3M0.0%+87,556
Braidwell LP1,787,318$69.6M2.7%−31,347
Jupiter Topco LLC1,526,006$59.5M0.0%New
Rtw Investments, LP1,487,934$58.0M0.5%No change
Boxer Capital Management, LLC1,477,600$57.6M4.3%+116,600
TCG Crossover Management, LLC1,445,538$56.3M1.4%No change
ICONIQ Capital, LLC1,266,563$49.3M1.4%No change
Geode Capital Management, LLC1,062,955$41.4M0.0%+62,544
Ikarian Capital, LLC1,059,730$41.3M6.8%−206,065
Artisan Partners Limited Partnership968,037$37.7M0.1%+277,715
Wellington Management Group Llp793,613$30.9M0.0%+357,284
Board of Trustees of The Leland Stanford Junior University691,767$27.0M5.1%No change
Silverarc Capital Management, LLC546,256$21.3M2.4%−445,674
Vanguard Portfolio Management LLC532,819$20.8M0.0%+167,768
Adage Capital Partners Gp, L.l.c.500,000$19.5M0.0%−75,000
Squadron Capital Management LLC500,000$19.5M6.7%+120,000
Two Sigma Investments, LP473,001$18.4M0.0%+373,533
Morgan Stanley435,029$16.9M0.0%−80,835
Bank Of America Corp /de/383,709$14.9M0.0%+83,353
Boone Capital Management LLC378,010$14.7M3.4%+96,678
Northern Trust Corp366,827$14.3M0.0%−24,522

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

2 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Nov 8, 2022Christopher L. Jacobs, HouseSale$1,001 - $15,000−1084.4%Report
Jul 18, 2022Christopher L. Jacobs, HouseBuy$1,001 - $15,000+763.1%Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36